Home
Resources
Follow portfolio news
...

A fast-growing company. Vivacy continues to grow in a booming dermal filler sector

Published on
6/9/2023
Amended on
4/11/2026
0
minute(s)
Odyssey 2022
Vivacy products
The dermal filler market is expected to grow by an average of 7.5% between 2023 and 2033, from $5 billion in 2021 to $6.7 billion by 2031. Vivacy, a Rhône-Alpes-based company founded by Waldemar Kita, is a world leader in this field, with sales exceeding 64 million euros in 2022.
By
Damien Hélène
Damien Hélène
A fast-growing company. Vivacy continues to grow in a booming dermal filler sector
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

The dermal filler market is expected to grow by an average of 7. 5% between 2023 and 2033. This is according to a new study by Future Marketing Insights.

The dermal filler market represented $5 billion in 2021. It should exceed $5.2 billion in 2022, reaching $6.7 billion by 2031.

This growth can be explained by the steady rise in demand for facelifts and corrections to certain parts of the face in growth markets such as the United States, Brazil,Germany and Malaysia.

Based in the Rhône-Alpes region, Vivacy has established itself as a world leader in hyaluronic acid-based dermal fillers.

Featured in the Odyssey Vintage Altaroc Odyssey , the company—founded by the Franco-Polish entrepreneur Waldemar Kita—saw its revenue exceed 64 million euros in 2022, marking a 28% increase year-over-year.

Its products, exported to over 85 countries, are used in non-invasive medical aesthetic procedures. Hyaluronic acid injections are used to fill bags under the eyes, smooth wrinkles and eliminate scars.

Other content in this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
News from the Vintage Altaroc Companies
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
22
2026-10-22
From elite sports to medical AI: what's new in the portfolio Altaroc
Follow portfolio news
From elite sports to medical AI: what's new in the portfolio Altaroc
Software adopted by every NFL team, AI agents that have already conducted 180 million interactions with patients, and a platform used by nearly one in five Fortune 500 companies. A look at nine acquisitions by the " Vintage "Odyssey over the past three months.
Article
|
19
2026-10-19
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
08
2026-10-08
A triptych illustrating the sports, health, and business sectors for corporate news from Vintage Altaroc
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
23
2026-09-23
A triptych illustrating the tech, aerospace, and digital sectors for company news from Vintage Altaroc
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
07
2026-09-07
Interview with Raul Villar, CEO of Optro
Follow portfolio news
Interview with Raul Villar, CEO of Optro
Raul Villar Jr. unveils his platform's global growth strategy, powered by AI, and his partnership with Hg
Video
|
13
2026-08-13
Interview with Chris Maclin, CEO of Empyrean
Follow portfolio news
Interview with Chris Maclin, CEO of Empyrean
In Boston, Chris Maclin, CEO of Empyrean, explains how his technology platform protects banks and modernizes risk management
Video
|
29
2026-05-29
Interview with Ian Drysdale, CEO of One Inc.
Follow portfolio news
Interview with Ian Drysdale, CEO of One Inc.
Learn about the career of Ian Drysdale, CEO of One Inc, a specialist in payment infrastructure for the insurance industry.
Video
|
09
2026-04-09
Interview with Daniel Baker, CEO of Healthdrive
Follow portfolio news
Interview with Daniel Baker, CEO of Healthdrive
In Boston, Daniel Baker, CEO of HealthDrive, shares his vision for sustainable growth with a human impact.
Video
|
29
2026-01-29
Interview Jeff Wessler - CEO Heartbeat
Follow portfolio news
Interview Jeff Wessler - CEO Heartbeat
Dr. Jeff Wessler, founder of Heartbeat Health, pioneer of virtual-first cardiology in the United States
Video
|
25
2025-11-25
Special report - Focus on the United States: 10 hypergrowth companies
Follow portfolio news
Special report - Focus on the United States: 10 hypergrowth companies
As the historic driving force behind global private equity, the United States is home to some of the most dynamic companies on the planet. This report highlights 10 hyper-growth American companies, backed by private equity, at the heart of key economic sectors.
File
|
12
2024-03-12
No articles in this category yet.
Welcome to Altaroc
In accordance with applicable regulations, we ask that you complete your profile. This step is required to access the content and services offered on our websites.
Please fill out your profile to access the site
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Select your language and investor profile to continue
Select your investor profile to continue
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.